See the difference between your comment on my factual post and pfeifers -
"I don't think we've been in such a position (remainong capital/high expenditure) before, therefore this I believe marks the first time for the auditor to make such statement."
You
"This is relatively standard in the biotech sector. Nothing unusual at all IMO."
CYP Price at posting:
20.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)